Reig Jofre informs on the new commercial activity in the Philippines

Reig Jofre continues to progress on its penetration in Asia with the marketing of an injectable antibiotic in the Philippines

  • Reig Jofre begins the marketing in the Philippines of Bizafrox (cefuroxime) 750mg, a cephalosporanic injectable indicated in bacterial infections.
  • The Asian market is one of the strategic markets for Reig Jofre, which went from 4% to 7% in the company’s sales contribution in2016.
  • Reig Jofre is finalizing the registration of new products for this market.